# Remicade® Crohn's Disease Registry Across Canada (Study P02793)

> **NCT00755937** · — · TERMINATED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 556 (actual)

## Conditions studied

- Crohn's Disease

## Interventions

- **OTHER:** Data collection post infusion

## Key facts

- **NCT ID:** NCT00755937
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2002-02
- **Primary completion:** 2007-09
- **Final completion:** 2007-09
- **Target enrollment:** 556 (ACTUAL)
- **Why stopped:** Satisfied a post-marketing commitment to Canadian Health Authorities.
- **Last updated:** 2015-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00755937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00755937, "Remicade® Crohn's Disease Registry Across Canada (Study P02793)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00755937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*